Abstract
Recent studies indicate that the midcycle gonadotropin surge in the human occurs without an increase in hypothalamic gonadotropin-releasing hormone (GnRH) pulse frequency. In addition, previous studies employing a GnRH antagonist to provide a semiquantitative estimate of endogenous GnRH secretion suggest that the overall amount of GnRH secreted is decreased at the time of the surge. To investigate the hypothesis that a normal gonadotropin surge can be generated in the human with a decreased amount of GnRH at the midcycle, 7 GnRH-deficient subjects underwent two cycles of a physiologic regimen of intravenous pulsatile GnRH therapy. In the control cycle, 75 ng/kg/bolus of GnRH, a dose known to be sufficient for folliculogenesis, was administered throughout the cycle, using physiological frequencies. In a second cycle, the bolus dose of GnRH was decreased by one-half log order to 25 ng/kg just prior to the luteinizing hormone surge and returned to 75 ng/kg after documented ovulation. All cycles were ovulatory. The peak luteinizing hormone level (77.4±9.7 vs. 67.5±17.6 IU/l) did not differ between the control and decreased GnRH cycles. There was no difference in the peak serum estradiol level (475.8±144.1 vs. 493.2±93.0 pg/ml), follicular phase length (15.0±1.3 vs. 14.8±0.6 days), or progesterone level (22.4±5.1 vs. 34.8±5.7 ng/ml) on day 6 of the luteal phase in the control and decreased GnRH cycles, respectively. Three pregnancies were achieved in each of the control and reduced GnRH cycles. We conclude that a decreased overall amount of GnRH generates a normal midcycle gonadotropin surge and has no significant impact on luteal phase adequacy or fertility. These results provide further evidence that a decrease in endogenous hypothalamic GnRH secretion may occur at the midcycle in normal women. This study also provides evidence that the GnRH requirements for normal follicular and luteal phase dynamics may well be greater than those required for generation of a normal midcycle gonadotropin surge and ovulation in women.
References
1.
Wildt L, Hauser A, Hutchison JS, Marshall G, Knobil E: Estradiol as a gonadropin releasing hormone in the rhesus monkey. Endocrinology 1981;108:2011–2013.
2.
Ferin M, Rosenblatt H, Carmel PW, Antunes JL, Van de Wiele RL: Estrogen-induced gonadotropin surges in female rhesus monkeys after pituitary stalk section. Endocrinology 1979;104:50–52.
3.
Nakai Y, Plant TM, Hess DL, Keogh EJ, Knobil E: On the sites of the negative and positive feedback action of estradiol in the control of gonadotropin secretion in the rhesus monkey. Endocrinology 1978;102:1008–1014.
4.
Gharib SD, Wierman ME, Shupnik MA, Chin WW: Molecular biology of the pituitary gonadotropins. Endocr Rev 1990;11:177–198.
5.
Jaffe RB, Keye WR: Estradiol augmentation of pituitary responsiveness to gonadotropin-releasing hormone in women. J Clin Endocrinol Metab 1974;39:850–855.
6.
Wang CF, Yen SSC: Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle. J Clin Invest 1975;55:201–204.
7.
Lasley BL, Wang CF, Yen SSC: The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. J Clin Endocrinol Metab 1975;41:820–826.
8.
Sarkar DK, Chiappa SA, Fink G, Sherwood NM: Gonadotropin-releasing hormone surge in pro-oestrous rats. Nature 1976;264:461–463.
9.
Levine JE, Ramirez VD: Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectomy, as estimated with push-pull cannulae. Endocrinology 1982;111:1439–1448.
10.
Moenter SM, Caraty A, Locatelli A, Karsch FJ: Pattern of gonadotropin-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: Existence of a preovulatory GnRH surge. Endocrinology 1991;129:1175–1182.
11.
Clarke IJ, Thomas GB, Yao B, Cummins JT: GnRH secretion throughout the ovine estrous cycle. Neuroendocrinology 1987;46:82–88.
12.
Pau K, Berria M, Hess DL, Spies HG: Preovulatory gonadotropin-releasing hormone surge in ovarian-intact rhesus macaques. Endocrinology 1993;133:1650–1656.
13.
Karsch FJ, Bowen JM, Caraty A, Evans NP, Moenter SM: Gonadotropin-releasing hormone requirements for ovulation. Biol Reprod 1997;56:303–309.
14.
Freeman MC: The neuroendocrine control of the ovarian cycle of the rat; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press 1994, pp 659–709.
15.
Knobil E, Plant TM, Wildt L, Belchetz PE, Marshall G: Control of the rhesus monkey menstrual cycle: Permissive role of hypothalamic gonadotropin-releasing hormone. Science 1980;207:1371–1373.
16.
Adams JM, Taylor AE, Schoenfeld DA, Crowley WF Jr, Hall JE: The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 1994;79:858–864.
17.
Martin K, Santoro N, Hall J, Filicori M, Wierman M, Crowley WF Jr: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab 1990;71:1081A–1081G.
18.
Filicori M, Santoro N, Merriam GR, Crowley WF Jr: Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986;62:1136–1144.
19.
Reame N, Sauders SE, Kelch RP, Marshall JC: Pulsative gonadotropin secretion during the human menstrual cycle: Evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984;59:328–337.
20.
Djahanbakhch O, Warner P, McNeilly AS, Baird DT: Pulsatile release of LH and oestradiol during the periovulatory period in women. Clin Endocrinol (Oxf) 1984;20:579–589.
21.
Rossmanith WG, Liu CH, Laughlin GA, Mortola JF, Suh BY, Yen SSC: Relative changes in LH pulsatility during the menstrual cycle: Using data from hypogonadal women as a reference point. Clin Endocrinol (Oxf) 1990;32:647–660.
22.
Steele PA, McDonnell LF, Judd SJ: Activity of gonadotropin-releasing hormone neurons during the preovulatory luteinizing hormone surge. Fertil Steril 1986;45:179–184.
23.
Santoro N, Wierman ME, Filicori M, Waldstreicher J, Crowley WF Jr: Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: Effects of dosage. J Clin Endocrinol Metab 1986;62:109–116.
24.
Leyendecker G, Struve T, Plotz EJ: Induction of ovulation with chronic intermittent (pulsatile) administration of LH-RH in women with hypothalamic and hyperprolactinemic amenorrhea. Arch Gynecol 1980;229:177–190.
25.
Crowley WF Jr, McArthur JW: Stimulation of the normal menstrual cycle in Kallmann’s syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J Clin Endocrinol Metab 1980;51:173–175.
26.
Filicori M, Flamigni C, Campaniello E, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A, Valdiserri A: Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle. Am J Physiol 1989;257:E930–E936.
27.
Clayton RN, Royston JP, Chapman J, Wilson M, Obhrai M, Sawers RS, Lynch SS: Is changing hypothalamic activity important for control of ovulation? Br Med J 1987;295:7–12.
28.
Hall JE, Taylor AE, Martin K, Rivier J, Schoenfeld DA, Crowley WF Jr: Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci USA 1994;91:6894–6898.
29.
Filicori M, Butler JP, Crowley WF Jr: Neuroendocrine regulation of the corpus luteum in the human. J Clin Invest 1984;73:1638–1647.
30.
Crowley WF Jr, Beitins IZ, Vale W, Kliman B, Rivier J, Rivier C, McArthur JW: The biologic activity of a potent analogue of gonadotropin releasing hormone in normal and hypogonadotropic men. N Engl J Med 1980;302:1052–1057.
31.
Whitcomb RW, O’Dea LSL, Finkelstein JS, Heavern DM, Crowley WF Jr: Utility of free alpha-subunit as an alternative neuroendocrine marker of gonadotropin-releasing hormone (GnRH) stimulation of the gonadotroph in the human: Evidence from normal and GnRH-deficient men. J Clin Endocrinol Metab 1990;70:1654–1661.
32.
Levine JE, Pau KF, Ramirez VD, Jackson GL: Simultaneous measurement of luteinizing hormone-releasing hormone and luteinizing hormone release in the unanesthetized, ovariectomized sheep. Endorinology 1982;111:1449–1455.
33.
Carmel PW, Araki S, Ferin M: Pituitary stalk portal blood collection in rhesus monkeys: Evidence for pulsatile release of GnRH. Endocrinology 1976;99:243–248.
34.
Caratay A, Locatelli A, Martin GB: Biphasic response in the secretion of gonadotropin-releasing hormone in ovariectomized ewes injected with oestradiol. J Endocrinol 1989;123:375–382.
35.
Ross EM, Gilman AG: Pharmacodynamics: Mechanisms of drug action and the relationship between drug concentration and effect; in Gilman AG, Goodman LS, Rall TW, Murad F (eds): Goodman and Gilman’s The Pharmacologic Basis of Therapeutics. New York, Macmillan, 1985, pp 35–48.
36.
Cicero TJ, Owens DP, Schmoeker PF, Meyer ER: Morphine induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat. J Pharmacol Exp Ther 1983;225:34–41.
37.
Ferin M, Van Vugt D, Wardlaw S: The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog Horm Res 1984;40:441–485.
38.
Clayton RN: Gonadotrophin-releasing hormone: Its action and receptors. J Endocrinol 1989;120:11–19.
39.
Phillips DJ, Cummins JT, Clarke IJ: Effect of modifying gonadotropin-releasing hormone input before and after the oestrogen-induced LH surge in ovariectomized ewes with hypothalamo-pituitary disconnection. J Endocrinol 1990;127:223–233.
40.
Savoy-Martin RT, Schwartz NB: Pituitary gonadotropin-releasing hormone receptors during the rat estrous cycle. Science 1980;209:942–944.
41.
Adams TE, Normal RL, Spies HG: Gonadtropin-releasing hormone receptor binding and pituitary responsiveness in estradiol-primed monkeys. Science 1981;213:1388–1390.
42.
Di Zerega GS, Hodgen GD: Folliculogenesis in the primate ovarian cycle. Endocr Rev 1981;2:27–49.
43.
Moenter SM, Brand RC, Karsch FJ: Dynamics of gonadotropin-releasing hormone (GnRH) secretion during the GnRH surge: Insights into the mechanism of GnRH surge induction. Endocrinology 1992;130:2978–2984.
44.
Clarke IJ: Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes. Endocrinology 1993;133:1624–1632.
45.
Kaynard AH, Malpaux B, Robinson JE, Wayne NL, Karsch FJ: Importance of pituitary and neural actions of estradiol in induction of the luteinizing hormone surge in the ewe. Neuroendocrinology 1988;48:296–303.
46.
Evans NP, Dahl GE, Caraty A, Padmanabhan V, Thrun LA, Karsch FJ: How much of the gonadotropin-releasing hormone (GnRH) surge is required for generation of the luteinizing hormone surge in the ewe? Duration of the endogenous GnRH signal. Endocrinology 1996;137:4730–4737.
47.
Xia L, Van Vugt D, Alston EJ, Luckhaus J, Ferin M: A surge of gonadotropin-releasing hormone accompanies the estradiol-induced gonadotropin surge in the rhesus monkey. Endocrinology 1992;131:2812–2820.
48.
Levine JE, Norman RL, Gliessman PM, Oyama TT, Bangsberg DR, Spies HG: In vivo gonadotropin-releasing hormone release and serum luteinizing hormone measurements in ovariectomized, estrogen-treated rhesus macaques. Endocrinology 1985;117:711–721.
49.
Normal RL, Gliessman P, Lindstrom SA, Hill J, Spies HG: Reinitation of ovulatory cycles in pituitary stalk-sectioned rhesus monkeys: Evidence for a specific hypothalamic message for the preovulatory release of luteinizing hormone. Endocrinology 1982;111:1874–1882.
50.
Dubourdieu S, Charbonnel B, D’Acremont MF, Carreau S, Spitz IM, Bouchard P: Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (nal-glu) during the periovulatory period: The luteinizing hormone surge requires secretion of GnRH. J Clin Endocrinol Metab 1994;78:343–347.
51.
Kolp LP, Pavlou SN, Urban RJ, Rivier JC, Vale WW, Veldhuis JD: Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women. J Clin Endocrinol Metab 1992;75:993–997.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
